High PVC and PAC Burden: Definitions and Diagnostic Work-Up
Defining High Burden
For PVCs, a "high burden" is generally defined as >10-15% of total heartbeats over 24 hours, with >24% particularly suggestive of PVC-induced cardiomyopathy, while frequent PVCs are defined as >30 PVCs per hour or at least 1 PVC on a 12-lead ECG 1, 2. The threshold of 15% is particularly important as it represents the point where referral to an arrhythmia specialist should be considered in patients with left ventricular dysfunction 3.
For PACs, the evidence is less clear regarding specific thresholds for clinical significance. Unlike PVCs, PAC burden does not correlate with cardiomyopathy development, even at high frequencies 4. However, high PAC burden does correlate with increased supraventricular tachycardia episodes and atrial fibrillation burden 4.
Key Burden Thresholds:
- >30 PVCs/hour: Marker of increased cardiovascular risk and mortality 1
- >10% PVC burden: Acceptable marker of increased risk in structural heart disease 2
- >15% PVC burden: Consider specialist referral if LV dysfunction present 3
- >24% PVC burden with short coupling interval (<300 ms): Highly suggestive of PVC-induced cardiomyopathy 2
Diagnostic Work-Up
Initial Evaluation (All Patients)
The work-up should focus on identifying underlying structural heart disease, assessing for reversible triggers, and quantifying the arrhythmia burden to determine risk of cardiomyopathy.
1. History - Focus on:
- Symptom characterization (palpitations, dyspnea, syncope, fatigue, chest pain)
- Timing and triggers (exercise, meals, caffeine, alcohol, stress)
- Family history of sudden cardiac death or cardiomyopathy
- Medication review (sympathomimetics, stimulants)
- Substance use (caffeine, alcohol, illicit drugs)
2. 12-Lead ECG Analysis:
- PVC morphology: Right ventricular outflow tract (RVOT) origin (inferior axis, left bundle pattern) suggests benign etiology; other origins may indicate structural disease
- Coupling interval: Short coupling (<300 ms) suggests PVC-induced cardiomyopathy 2
- Multifocal vs. unifocal: Multifocal PVCs associated with worse outcomes 1
- QRS duration of sinus beats: Assess for underlying conduction disease
- Baseline ECG abnormalities: Signs of ischemia, hypertrophy, or infiltrative disease
3. Transthoracic Echocardiography (Mandatory):
- Left ventricular ejection fraction (LVEF)
- Regional wall motion abnormalities
- Chamber dimensions and wall thickness
- Valvular abnormalities
- Right ventricular function
Extended Monitoring
4. 24-48 Hour Holter or Extended Ambulatory Monitoring:
Perform in ALL patients to quantify burden 3. The evidence shows that 7-14 day monitoring increases detection rates compared to 24-hour monitoring 5.
Indications for extended monitoring:
- Quantify PVC/PAC burden percentage
- Assess for nonsustained ventricular tachycardia (NSVT)
- Correlate symptoms with arrhythmias
- Evaluate circadian pattern
5. Exercise Stress Testing:
Perform when:
- Exertional symptoms present
- Need to assess for exercise-induced arrhythmias
- Screening for ischemia as underlying cause
- Evaluating suppression of PVCs with exercise (suggests benign etiology)
Advanced Testing (Selective Use)
6. Cardiac MRI with Gadolinium:
Strongly consider when:
- Unexplained LV dysfunction present
- Suspicion for infiltrative disease (sarcoidosis, amyloidosis)
- Concern for myocarditis
- Arrhythmogenic right ventricular cardiomyopathy suspected
- Identifying myocardial scar that may guide ablation strategy
7. Coronary Angiography:
Indicated when:
- Ischemic symptoms present
- Risk factors for coronary disease with new LV dysfunction
- Age and risk profile warrant evaluation
- Regional wall motion abnormalities on echo
8. Electrolyte Panel and Thyroid Function:
- Assess for hypokalemia, hypomagnesemia, hypocalcemia
- Rule out hyperthyroidism
Risk Stratification Algorithm
Low Risk (Observation/Conservative Management):
- PVC burden <10%
- Normal LVEF and cardiac structure
- No symptoms or mild symptoms
- No family history of sudden death
- RVOT morphology
Intermediate Risk (Close Monitoring):
- PVC burden 10-15%
- Normal or mildly reduced LVEF (45-50%)
- Symptomatic
- Consider repeat echo in 6-12 months
High Risk (Specialist Referral):
- PVC burden >15% with any LV dysfunction 3
- PVC burden >24% regardless of LVEF 2
- LVEF <50% with any PVC burden
- Syncope or presyncope
- Family history of sudden cardiac death
- NSVT on monitoring 1
- Structural heart disease present
Critical Pitfalls to Avoid
Assuming all frequent PVCs are benign: Even in the absence of symptoms, PVC burden >15-24% can cause reversible cardiomyopathy 2, 6
Treating PACs like PVCs: PAC burden does not cause cardiomyopathy and should not prompt the same aggressive work-up for structural disease 4
Using antiarrhythmic drugs to suppress PVCs for prognostic benefit: Class I sodium channel blockers increase mortality in post-MI and reduced LVEF patients 1. Suppression does not improve outcomes unless treating PVC-induced cardiomyopathy.
Relying solely on 12-lead ECG: The C-statistic for predicting high-burden PVCs from 12-lead ECG is only 0.79 7. Extended monitoring is essential for accurate burden quantification.
Missing reversible causes: Always assess for electrolyte abnormalities, thyroid disease, alcohol use, and medication effects before pursuing invasive strategies.
Delaying referral in PVC-induced cardiomyopathy: When PVC burden >15-24% with reduced LVEF, catheter ablation can restore ventricular function 2, 6. Early referral improves outcomes.